Explore more about: Respiratory Disease

Researchers at Ohio State University have developed nanocarriers derived from mice skin cells that reduced lung inflammation in mice. Further research could lead to a treatment for acute respiratory distress syndrome and other conditions.

NIH researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases. For every diagnosed COVID-19 case in this time frame, the researchers estimate that there were 4.8 undiagnosed cases, representing an additional 16.8 million cases by July alone.

The COVID-19 Testing Impact Calculator is a free resource that shows how different approaches to testing and other mitigation measures, such as mask use, can curb the spread of the virus in any organization.

The COVID-19 Test Us program was conceived soon after the RADx launch in April to facilitate clinical studies for testing technologies in the real-word setting.

NIH has awarded seven contracts to companies and academic institutions to develop digital health solutions that help address the COVID-19 pandemic.

NIH announced $129.3 million in scale-up and manufacturing support for a new set of COVID-19 testing technologies as part of RADx. These tests add to initial awards made to seven companies on July 31, 2020.

Researchers at the University of Memphis-based Center of Excellence for Mobile Sensor Data-to-Knowledge (MD2K) have introduced a new mobile app that may support physical distancing during the COVID-19 pandemic. MD2K is supported by NIH with a grant administered by the NIBIB.

A new study has begun recruiting at the National Institutes of Health in Bethesda, Maryland, to determine how many adults in the United States without a confirmed history of infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), have antibodies to the virus.

Bioengineers have developed a 3D printing technique that creates the interacting networks for transport of air, blood, and other bodily fluids—a major step toward 3D printed replacement organs.

A team of researchers have adapted optical coherence tomography to detect bacterial biofilms often associated with ventilator-assisted pneumonia in the ICU.